January 23, 2026
New Thyroid Guidelines Transform Fertility Care
The American Society for Reproductive Medicine (ASRM) has updated guidelines on subclinical hypothyroidism, advising against routine thyroid testing for asymptomatic individuals. Studies show minimal impact of mild TSH elevations on fertility, prompting Shady Grove Fertility to adopt targeted testing for patients with symptoms or risk factors.
Key Takeaways
ASRM’s Subclinical Hypothyroidism Guidelines for Fertility Patients
The ASRM now recommends against routine thyroid testing for asymptomatic individuals without a history of thyroid disease. This shift is based on evidence showing mild TSH elevations do not significantly affect fertility outcomes in most cases.
Why Routine Thyroid Testing Isn’t Needed for Asymptomatic Fertility Patients
Research indicates that asymptomatic patients with mild TSH elevations do not require treatment or testing unless they exhibit symptoms like fatigue, weight changes, or cold intolerance. This reduces unnecessary interventions and anxiety during fertility evaluations.
How Shady Grove Fertility Adapts Testing Based on ASRM Updates
Shady Grove Fertility will now perform thyroid testing only for patients with a personal/family history of thyroid disease, symptoms, or risk factors like autoimmune conditions. This targeted approach aligns with evidence-based guidelines.
Streamlined Fertility Testing Saves Time and Reduces Anxiety
Eliminating routine thyroid tests for asymptomatic patients simplifies fertility evaluations, saving costs and reducing stress for those undergoing treatment without clinical indications for testing.
Personalized Fertility Care Based on Individual Risk Factors
The updated guidelines emphasize tailored care by focusing on clinical indicators rather than blanket testing. Patients with thyroid symptoms or risk factors still receive necessary evaluations to optimize outcomes.
Source: Read full article